A Multicenter Prospective Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Crizotinib (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Anaplastic large cell lymphoma
- Focus Therapeutic Use
- 28 Dec 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 22 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 03 Jul 2015 New trial record